Opinion on Pharmaceuticals

Published within

« | ... | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | ... | » »|

Type Product title / description Pub Price
ResearchWire
ResearchWire

Antiarrhythmics market: new product launches to reinvigorate growth

Published By Datamonitor
21 Jul 2006
Expert View
Expert View

Antibacterial hope lies in clever drugs for superbugs

Branded antibacterials had best beware: the antibacterial market is currently best described as saturated, highly segmented and increasingly flooded with generics. Furthermore, bacterial drug-resistance is threatening currently marketed drugs, although this represents an opportunity for the more audacious drug maker.

Published By Datamonitor
19 Aug 2005
CommentWire
CommentWire

Antibiotics: use drops among US children

A new study has reported a substantial decrease in pediatric antibiotic prescriptions between 1996 and 2000. The development shows the success of a wider campaign to reduce overuse of antibiotics - a serious problem that contributes to the development of disease-resistant forms of common bacteria.

Published By Datamonitor
04 Sep 2003
CommentWire
CommentWire

Antidepressants: FDA research may lead to adult warnings

The Food and Drug Administration (FDA) is set to examine the potential link between antidepressants and increased suicidal tendencies in adults. Even if the FDA finds such a link however, the likely outcome will be proposals for more 'black box' labels and its ultimate impact on antidepressant revenues will be relatively slight.

Published By Datamonitor
01 Oct 2004
ResearchWire
ResearchWire

Antidyslipidemics: combination therapy usage varies widely by region

Published By Datamonitor
09 Feb 2006
ResearchWire
ResearchWire

Antidyslipidemics: statins secure in the top spot

Published By Datamonitor
17 Feb 2006
CommentWire
CommentWire

Antigenics: Oncophage vaccine shows promise

Antigenics' [AGEN] most advanced pipeline treatment, Oncophage, is showing promising phase II activity where the vaccine has been shown to stimulate the body's immune cells. Currently no vaccines are approved for the treatment of cancer in the seven major markets, creating a lucrative investment opportunity in the coming years, but physician reservations will need to be overcome.

Published By Datamonitor
06 Oct 2003
ResearchWire
ResearchWire

Antihypertensives: ARBs at the heart of the market

Published By Datamonitor
27 Mar 2006
ResearchWire
ResearchWire

Antihypertensives: strong growth in global sales

Published By Datamonitor
08 Apr 2005
ResearchWire
ResearchWire

Anxiety disorders: global sales set to slide

Published By Datamonitor
03 May 2006

« | ... | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | ... | » »|

No help is available.